GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS

GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS

Show other versions (1)

<p>Despite a more than fifty-year period after the introduction of glucocorticoids (GCs) into therapeutic practice; they have headed the list of anti-inflammatory drugs so far. The paper analyzes current views on the terminology of GCs, mechanism of action, standardization of indications for t...

Full description

Bibliographic Details
Main Authors: T. M. Reshetnyak, N. V. Seredavkina, I. S. Dydykina, E. I. Nasonov
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Klinicist
Subjects:
glucocorticoids
systemic lupus erythematosus
Online Access:http://klinitsist.abvpress.ru/index.php/Klin/article/view/6
id doaj-7c92b2f35cae49e2a7724a5efe2adaa1
record_format Article
spelling doaj-7c92b2f35cae49e2a7724a5efe2adaa12020-11-24T21:03:50ZrusABV-pressKlinicist1818-83382014-07-0173-4142621GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUST. M. Reshetnyak0N. V. Seredavkina1I. S. Dydykina2E. I. Nasonov3V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical SciencesV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical SciencesV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical SciencesV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences<p>Despite a more than fifty-year period after the introduction of glucocorticoids (GCs) into therapeutic practice; they have headed the list of anti-inflammatory drugs so far. The paper analyzes current views on the terminology of GCs, mechanism of action, standardization of indications for their use in systemic lupus erythematosus, choice of a dose and a regimes of the drugs, as well as the rates of their decrease; the authors also review Russian and foreign literature on this problem and their own data.</p>http://klinitsist.abvpress.ru/index.php/Klin/article/view/6glucocorticoidssystemic lupus erythematosus
collection DOAJ
language Russian
format Article
sources DOAJ
author T. M. Reshetnyak
N. V. Seredavkina
I. S. Dydykina
E. I. Nasonov
spellingShingle T. M. Reshetnyak
N. V. Seredavkina
I. S. Dydykina
E. I. Nasonov
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
Klinicist
glucocorticoids
systemic lupus erythematosus
author_facet T. M. Reshetnyak
N. V. Seredavkina
I. S. Dydykina
E. I. Nasonov
author_sort T. M. Reshetnyak
title GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_short GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_full GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_fullStr GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_full_unstemmed GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_sort glucocorticoids in the therapy of systemic lupus erythematosus
publisher ABV-press
series Klinicist
issn 1818-8338
publishDate 2014-07-01
description <p>Despite a more than fifty-year period after the introduction of glucocorticoids (GCs) into therapeutic practice; they have headed the list of anti-inflammatory drugs so far. The paper analyzes current views on the terminology of GCs, mechanism of action, standardization of indications for their use in systemic lupus erythematosus, choice of a dose and a regimes of the drugs, as well as the rates of their decrease; the authors also review Russian and foreign literature on this problem and their own data.</p>
topic glucocorticoids
systemic lupus erythematosus
url http://klinitsist.abvpress.ru/index.php/Klin/article/view/6
work_keys_str_mv AT tmreshetnyak glucocorticoidsinthetherapyofsystemiclupuserythematosus
AT nvseredavkina glucocorticoidsinthetherapyofsystemiclupuserythematosus
AT isdydykina glucocorticoidsinthetherapyofsystemiclupuserythematosus
AT einasonov glucocorticoidsinthetherapyofsystemiclupuserythematosus
_version_ 1716772776093679616

Similar Items